Completed PHASE3 INTERVENTIONAL NCT00483132

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Sponsor: French Innovative Leukemia Organisation

Updated 5 times since 2017 Last updated: Jun 5, 2007 Started: Sep 30, 1994 Completion: Apr 30, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Leukemia, Lymphocytic, Acute and is currently completed. French Innovative Leukemia Organisation leads this study, which shows 5 recorded versions since 1994 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

French Innovative Leukemia Organisation

Data source: French Innovative Leukemia Organisation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Angers, France